Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 14;13:931153. doi: 10.3389/fimmu.2022.931153

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Beeckmans, Ambrocio, Bos, Vermaut, Geudens, Vanstapel, Vanaudenaerde, De Baets, Malfait, Emonds, Van Raemdonck, Schoemans, Vos and for the Leuven Lung Transplant Group

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Evolution of pulmonary function and chest CT over time. (A) Pulmonary function. (B) Chest CT. Evolution of pulmonary function over time in relation to lung transplantation (LTx) and allogeneic hematopoietic stem cell (Allo-HCT) for hereditary pulmonary alveolar proteinosis (A), which are indicated by dotted lines. Dots represent individual measurements of lung volumes (Liters), with connecting lines between measurements showing the trend of individual lung function parameters over time. Evolution of chest computed tomography (CT) function over time (B), with representative inspiratory phase images at 3 months, 6 months 1 year and 4 years post-lung transplantation (LTx). Allogeneic hematopoietic stem cell (Allo-HCT) was performed 11 months after prior lung transplantation. At 4.5 years after lung transplantation there is currently no evidence for chronic lung allograft dysfunction, graft-versus-host disease, or recurrence of hereditary pulmonary alveolar proteinosis. FVC, forced vital capacity; FEV1, forced expiratory volume in one second; FEF25-75, forced expiratory flow at 25–75% of forced vital capacity; TLC, total lung capacity; TLCO, transfer capacity of the lung, for the uptake of carbon monoxide (CO) (also called diffusing capacity for carbon monoxide).